digiMedical Solutions, Inc.(TM) Appoints Jason Whisenant to Advisory Board to Focus on High Margin Digital Prescriptions Softwar
April 14 2009 - 9:30AM
Marketwired
digiMedical Solutions, Inc. (TM) (PINKSHEETS: DGMS) today announced
the Company has appointed Jason Whisenant to its Advisory Board.
Mr. Whisenant will focus on the Company's sales and marketing
strategies, primarily as they relate to private labeling and
strategic partnerships. Since last year, the Company has
repositioned to focus on a high margin software revenue model,
selling its proprietary digital prescription software to both
clinics and pharmacies. Recently, the Company has also announced
developing relationships with other companies to allow them to
private label the Company's software in an effort to quickly
increase digiMedical sales channels and associated transaction
revenue.
Mr. Whisenant has over 15 years' experience in both strategic
marketing and sales advisory roles. After studying at the
University of Arkansas at Little Rock (UALR), Mr. Whisenant founded
and operated seven retail chain stores, which were eventually sold
as he began consulting small to medium companies on how to achieve
marketing goals. Mr. Whisenant is currently employed by a
NASDAQ-listed corporation in which Mr. Whisenant is architecting
new lines of business.
David Lee, digiMedical CEO, stated, "With Mr. Whisenant's robust
retail, supply management and E-commerce experience, I know he will
be able to provide incredible insight into how we can approach our
new software model. One of Mr. Whisenant's first suggestions was to
private label our products, a process which we have already begun.
We are excited Mr. Whisenant has accepted this role, and we look
forward to his input as we continue to make progress toward new
ventures."
Jason Whisenant commented, "Mr. Lee and I have known each other
almost 20 years, and I know the character and the determination he
brings to digiMedical. I am excited to advise both Mr. Lee and
digiMedical as the Company navigates the ever changing world of
sales and marketing. It will take lots of energy and fortitude to
move the Company's proven products into an E-commerce and private
label market, nevertheless after visiting with the key management
of the Company, I know we will be successful."
Separately, the Company recently launched a new interactive
corporate website. The new site, www.digimedical.com, offers
doctors, patients, pharmacists and investors a clear view of the
company's technology, service offerings and current news and
events. Utilizing the latest Microsoft technologies such as .NET,
AJAX and Microsoft SQL, the Company has developed a suite of
products to digitally manage the prescription process. The
company's products comply with all HIPAA and DEA requirements for
patient medical record security.
To be added to digiMedical's corporate e-mail list to receive
company updates, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)
digiMedical Solutions, Inc.? is a pharmacy and medical
technology company focused on developing next generation, digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that closely align the doctor, pharmacist and
patient. The company's planned growth will come from three
channels: direct marketing of the company's wireless based
d-prescription technology to physicians, direct marketing of the
company's digital call center services for refills and
reauthorization and partnering with independent pharmacy chains to
focus sales with the technology suite.
Forward-Looking Statement
Statements included in this press release which are not
historical in nature, are intended to be, and are hereby identified
as "Forward-Looking Statements" for purposes of safe harbor
provided by Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-Looking Statements may be identified by words
including "anticipate," "await," "envision," "foresee," "aim at,"
"believe," "intends," "estimates" including without limitation,
those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's
filings with the U.S. Securities and Exchange Commission.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: digiMedical Solutions, Inc. Investor Relations
214-722-3029 ir@digimedical.com www.digimedical.com
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From May 2024 to Jun 2024
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From Jun 2023 to Jun 2024